Bank of Montreal’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-818
Closed -$44K 4655
2016
Q1
$44K Sell
818
-1,863
-69% -$138K ﹤0.01% 3107
2015
Q4
$303K Buy
2,681
+494
+23% +$54.4K ﹤0.01% 2195
2015
Q3
$257K Sell
2,187
-10,763
-83% -$1.41M ﹤0.01% 2145
2015
Q2
$1M Buy
+12,950
New +$849K ﹤0.01% 1666
2015
Q1
Sell
-15,000
Closed -$484K 4473
2014
Q4
$484K Buy
+15,000
New +$450K ﹤0.01% 2075
2014
Q3
Sell
-3,640
Closed -$65K 4995
2014
Q2
$65K Buy
3,640
+640
+21% +$10.3K ﹤0.01% 3089
2014
Q1
$60K Sell
3,000
-3,000
-50% -$58.2K ﹤0.01% 3051
2013
Q4
$101K Sell
6,000
-4,000
-40% -$55.3K ﹤0.01% 2537
2013
Q3
$106K Hold
10,000
﹤0.01% 2486
2013
Q2
$56K Buy
+10,000
New +$60.5K ﹤0.01% 2680

Other funds holding ANAC

Bank of Montreal's ANAC Position: Q2 2016 in Review

Bank of Montreal sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 818 shares — an estimated $44K sold.

Bank of Montreal first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $1M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Bank of Montreal reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Bank of Montreal sold 818 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $44K.
  • Bank of Montreal first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
  • Bank of Montreal's ANACOR PHARMACEUTICALS INC COM position peaked at $1M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Bank of Montreal's 13F filing for Q2 2016, filed 25 Jul 2016.